Solomon Partners
1
110M
1
0.03
- Areas of investment
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.03
- Investments by industry
- Mechanical Design (1)
- Mechanical Engineering (1)
- Software (1)
- Quantum Computing (1)
- Electronics (1)
- Investments by region
- United States (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 35M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ColdQuanta | 01 Nov 2022 | Software, Electronics, Quantum Computing, Mechanical Engineering, Mechanical Design | Early Stage Venture | 110M | United States, Boulder, Colorado |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MeWe | Sep 10, 2024 | AI, Algorithmic Manipulation Avoidance, Blockchain, Cloud Storage, Privacy, Social Media, Social Network, Web3 | Early Growth stage | 6000000 USD |  Los Angeles, California |
| Onebrief | Aug 21, 2024 | AI-enhanced tools, AI-enhanced Tools, Cloud-native platform, Collaboration, Military staff workflows, Military Staff Workflows, Operational planning, Operational Planning, Software Platform | Growth stage | 53000000 USD | Honolulu, Hawaii |
| Ensoma | Oct 1, 2023 | Autoimmune Disease, Cancer, DNA Editing, Genetic Disease, Genetic Medicines, Genome Engineering, Genomic Medicines, Hematopoietic Stem Cell Engineering, Immuno-oncology, Inherited Conditions, In Vivo Delivery, Sickle Cell Disease | Growth stage | 85000000 USD | Boston, Massachusetts |
| Evommune | Apr 26, 2023 | Biotechnology, Immune-mediated Inflammatory Diseases, Immunology, Inflammatory Diseases, R&D | Growth stage | 50000000 USD | Palo Alto, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.